|
|
||||||||



*
The Hospital For Sick Children, Research Institute,
Division of Neurology, St. Michaels Hospital, and
Division of Laboratory Animal Services, Sunnybrook Hospital, and Departments of
Paediatrics and
¶ Medicine, University of Toronto, Toronto, Ontario, Canada; and
||
Department of Pediatrics, Division of Endocrinology, Childrens Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA 15260
Multiple sclerosis (MS) is a chronic autoimmune disease triggered by unknown environmental factors in genetically susceptible hosts. MS risk was linked to high rates of cow milk protein (CMP) consumption, reminiscent of a similar association in autoimmune diabetes. A recent rodent study showed that immune responses to the CMP, butyrophilin, can lead to encephalitis through antigenic mimicry with myelin oligodendrocyte glycoprotein. In this study, we show abnormal T cell immunity to several other CMPs in MS patients comparable to that in diabetics. Limited epitope mapping with the milk protein BSA identified one specific epitope, BSA193, which was targeted by most MS but not diabetes patients. BSA193 was encephalitogenic in SJL/J mice subjected to a standard protocol for the induction of experimental autoimmune encephalitis. These data extend the possible, immunological basis for the association of MS risk, CMP, and CNS autoimmunity. To pinpoint the same peptide, BSA193, in encephalitis-prone humans and rodents may imply a common endogenous ligand, targeted through antigenic mimicry.
This article has been cited by other articles:
![]() |
D. Otaegui, S. Mostafavi, C. C. A. Bernard, A. L. de Munain, P. Mousavi, J. R. Oksenberg, and S. E. Baranzini Increased Transcriptional Activity of Milk-Related Genes following the Active Phase of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis J. Immunol., September 15, 2007; 179(6): 4074 - 4082. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Seyfert-Margolis, T. D. Gisler, A. L. Asare, R. S. Wang, H. M. Dosch, B. Brooks-Worrell, G. S. Eisenbarth, J. P. Palmer, C. J. Greenbaum, S. E. Gitelman, et al. Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes: Results of a Blinded Controlled Study Diabetes, September 1, 2006; 55(9): 2588 - 2594. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mana, M. Goodyear, C. Bernard, R. Tomioka, M. Freire-Garabal, and D. Linares Tolerance induction by molecular mimicry: prevention and suppression of experimental autoimmune encephalomyelitis with the milk protein butyrophilin Int. Immunol., March 1, 2004; 16(3): 489 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guggenmos, A. S. Schubart, S. Ogg, M. Andersson, T. Olsson, I. H. Mather, and C. Linington Antibody Cross-Reactivity between Myelin Oligodendrocyte Glycoprotein and the Milk Protein Butyrophilin in Multiple Sclerosis J. Immunol., January 1, 2004; 172(1): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ascherio, K. L. Munger, E. T. Lennette, D. Spiegelman, M. A. Hernan, M. J. Olek, S. E. Hankinson, and D. J. Hunter Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study JAMA, December 26, 2001; 286(24): 3083 - 3088. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |